The influence of prostaglandin analogs on the retinal thickness after phacoemulsification with intraocular lens implantation in primary open-angle glaucoma patients

Cover Page


Cite item

Full Text

Abstract

Retinal OCT measurements were analyzed after phacoemulsification with intraocular lens (IOL) implantation in primary open-angle glaucoma (POAG) patients. A total of 190 patients (205 eyes) were examined. Two different groups were analyzed. Patients in Group 1 (32 eyes) had been treated with prostaglandin analogs before surgery (phacoemulsification or phacoemulsification + pressure lowering procedure) and after it when needed. However, these drops were stopped one day prior to surgery. Patients in Group 2 (173 eyes) were used as the control. The mean follow-up period after surgery was 12 months. During the entire follow-up period, in all patients had OCT monitoring at the 2nd-3rd day after surgery, 1 month, 2 months, 6 months, and 12 months. The OCT measurements were not statistically different between Group 1 (32 eyes) and Group 2 (173 eyes). According to our results, there was no significant influence of pre-operative prostaglandin use on the retinal thickness when compared to patients not using this therapy.

About the authors

Sergey Yuryevich Astakhov

I. P. Pavlov State Medical University of St. Petersburg

Email: astakhov73@mail.ru
MD, doctor of medical science, professor, head of the department. Department of Ophthalmology

Yuriy Sergeyevich Astakhov

I. P. Pavlov State Medical University of St. Petersburg

Email: astakhov73@mail.ru
MD, doctor of medical science, professor. Department of Ophthalmology

Medeya Vakhtangovna Gobedzhishvili

I. P. Pavlov State Medical University of St. Petersburg

Email: astakhov73@mail.ru
MD, candidate of medical science, ophthalmologist. Department of Ophthalmology

References

  1. Алексеев И. Б., Самойленко А. И., Адлейба О. А. и др. Влияние аналогов простагландинов на результаты факоэмульсификации катаракты у больных первичной открытоугольной глаукомой. Российский офтальмологический журнал. 2012; 2: 4-7.
  2. Астахов С. Ю. Современные методы хирургической реабилитации больных катарактой и глаукомой: Автореф. Дис. Д-ра мед. наук. ВМА СПб, 1999; 37.
  3. Добромыслов А. Н., Квасова М. Д. Экстракция катаракты посе антиглаукомной операции. Вест. Офт. 1986; 102(3): 20-1.
  4. Одабашьян С. А. Роль перекисного окисления липидов в возникновении воспалительной реакции после экстракции катаракты с имплантацией ИОЛ. Офтальмол. журн., 2000; 3: 53-6.
  5. Biro Z., Balla Z., Kovacs B. Change of foveal and perifoveal thickness measured by OCT after phacoemulsification and IOL implantation. Eye (Lond), 2008; 22(1): 8-12.
  6. Bito L. Z., Camras C. B., Gum G. G., Resul B. The Ocular Hypotensive Effects and Side Effects of Prostaglandins on the Eyes of Experimental Animals. Progress in Clinical and Biological Research, 1989; 78: 312-68.
  7. Lee A. J., Mc Cluskey P. Clinical and differential effects of rostaglandin analogs in the management of raised intraocular pressure and ocular hypertantion. Clin Ophthalmol, 2010; 4: 741-64.
  8. Lima M. C., Paranhos A., Salim S. et al. Visually significant cystoid macular oedema in pseudophakic and aphakic patients with glaucoma receiving latanoprost. J. Glaucoma, 2000; 9(4): 317-21.
  9. Shrivastava A. Prostaglandin Analogs and Cataract Surgery. Cataract & Refractive Surgery Today, 2008; July: 75-7.
  10. Toris C. B., Gabelt B. T., Kaufman P. L. Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction.Surv. Ophthalmol., 2008; 53(1): 107-120.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014 Astakhov S.Y., Astakhov Y.S., Gobedzhishvili M.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-65574 от 04 мая 2016 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies